Characterisation of Patients with Systemic Lupus Erythematosus in Malta: A Population Based Cohort Cross-Sectional Study

Magro, Rosalie; Borg, Andrew

doi:10.1155/2018/2385386

Cited by 16 publications

(10 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar to this work, a study developed in Minas Gerais that evaluated the nutritional status and the level of physical activity in patients with SLE, found a higher prevalence of overweight (35.9%) and obesity (28.3%) [18]. Another study that characterized SLE patients residing in Malta, identified a prevalence of 31.5% of overweight and 29.3% of obesity [8].…”

Section: Discussionsupporting

confidence: 68%

See 1 more Smart Citation

Sarcopenia e excesso de peso em mulheres portadoras de lúpus eritematoso sistêmico

Monteiro¹,

Cardoso²,

Oliveira³

et al. 2021

Rev Bras Fisiol Exerc

View full text Add to dashboard Cite

Objetivo: Investigar a prevalência de sarcopenia de acordo com as categorias de índice de massa corporal (IMC) em mulheres com lúpus eritematoso sistêmico assistidas por um hospital de ensino de Maceió, Alagoas. Métodos: Análise transversal com pacientes selecionadas por conveniência, que incluiu dados socioeconômicos, demográficos, clínicos, antropométricos e de sarcopenia. A avaliação antropométrica incluiu IMC, circunferências corpóreas, pregas cutâneas, análise de bioimpedância e percentual de gordura. A sarcopenia foi avaliada segundo os critérios diagnósticos propostos pelo European Working Group on Sarcopenia in Older People-EWGSOP (2019), que inclui um protocolo de triagem SARC-F, a força muscular, a quantidade muscular e o desempenho físico. Foi aplicado o teste de qui-quadrado de Pearson, adotando nível de significância de p < 0,05 e intervalo de confiança de 95%. Resultados: 62,8% das mulheres apresentaram excesso de peso, seguidas de 32,5% com eutrofia e 4,6% com desnutrição. Não foi detectada sarcopenia em nossa amostra. Contudo a triagem SARC-F apontou 17,5% possíveis casos de sarcopenia, enquanto 21,4% das pacientes tiveram provável sarcopenia de acordo com o critério de baixa força de preensão manual (FPM). Ainda, uma parcela da amostra apresentou redução de desempenho físico, sem diferenças estatísticas de acordo com as categorias de IMC. Ainda, 66,6% das mulheres com provável sarcopenia e todas aquelas triadas pelo SARC-F para sarcopenia, apresentaram excesso de peso. Conclusão: O desempenho, a força muscular diminuída e o elevado excesso de peso são alertas para a diminuição de funcionalidade muscular, ficando claro a necessidade do cuidado precoce desta população, bem como adaptações do instrumento avaliativo de sarcopenia para o LES.

show abstract

Section: Discussionsupporting

confidence: 68%

“…In addition to sarcopenia, other changes in body composition can be detected and include abnormalities in nutritional status. An increase in the prevalence of overweight / obesity and a proportion, albeit lower, of malnutrition have been identified [8].…”

Section: Introductionmentioning

confidence: 99%

Sarcopenia e excesso de peso em mulheres portadoras de lúpus eritematoso sistêmico

Monteiro¹,

Cardoso²,

Oliveira³

et al. 2021

Rev Bras Fisiol Exerc

View full text Add to dashboard Cite

show abstract

“…Systemic lupus erythematosus (SLE) is a chronic, autoimmune and multisystem disease with a large spectrum of clinical manifestations including the joints. 1 Despite multiple body systems affected by this disease, with the improvement of diagnosis and treatment, patients live longer and as a result are more prone to developing musculoskeletal symptoms, which become the most common long-term complaints for this illness. It is reported that more than 90% of the SLE patients are affected by arthritis or arthralgia.…”

Section: Introductionmentioning

confidence: 99%

Risk factors of perioperative complications and transfusion following total hip arthroplasty in systemic lupus erythematosus patients

Xiang

et al. 2019

Lupus

View full text Add to dashboard Cite

Background In recent years, hip arthroplasty rates in systemic lupus erythematosus (SLE) patients have been increasing rapidly. Although patients with SLE generally show beneficial or desirable functional outcomes following total hip arthroplasty (THA), it has been reported that SLE patients after THA have increased risk of postoperative complications, especially during the period of hospitalization. Objectives In the present study, we aimed to identify possible factors associated with complications or transfusion of THA in SLE patients during hospitalization. Methods The present study was a retrospective study conducted in Peking Union Medical College Hospital. Data were collected from medical records of patients who underwent THA from January 2012 to June 2018. The primary outcome variable was perioperative complications, which was defined as having one or more of the following conditions: high fever, infection, impaired wound healing, venous thrombosis of the lower extremities, hematoma, arrhythmia, implant complications. The secondary outcome was perioperative transfusion. Results During January 2012 to June 2018, 100 patients had taken the surgery of THA. After multivariate analysis, independent risk factors for perioperative complications were: age ≥ 45 years ( p = 0.001), SLE with other connective tissue diseases ( p = 0.029), high temperature ( p = 0.030), positive anti-dsDNA antibody ( p = 0.043), and Systemic Lupus International Collaborative Clinics/American College of Rheumatology (SLICC/ACR) Damage Index ≥ 3 ( p = 0.008). Independent risk factors for perioperative transfusion were bilateral THA ( p = 0.029), low hemoglobin ( p = 0.021) and abnormal renal function ( p = 0.021). Conclusion For SLE patients following THA, age > 45 years, SLE with other connective tissue disease, high temperature, positive anti-dsDNA antibody and SLICC/ACR Damage Index ≥ 3 were the risk factors of complications during hospitalization and bilateral THA, low hemoglobin and abnormal renal function were the risk factors of transfusion.

show abstract

“…This systematic review followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guideline [ 30 ]. The review was registered with PROSPERO—the International Prospective Register of Systematic Reviews CRD: 42020197495.…”

Section: Methodsmentioning

confidence: 99%

Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis

Gebrye

Mbada

2022

Rheumatol Int

View full text Add to dashboard Cite

Systemic lupus erythematosus (SLE) may be more prevalent among most ethnic groups in the low-and-middle income countries (LMICs), still these countries are under-represented in epidemiological data on SLE. The aim of this study was to review the prevalence and incidence of SLE in LMICs and use meta-analytic techniques. The MEDLINE, CINHAL, Web of Science, Scopus and Global Index Medicus databases were searched for relevant studies published up to July of 2022. Papers selected for full-text review were included in the systematic review if they provided the prevalence or incidence of SLE in LMICs and published in English language. The reference lists of included articles were also searched for additional studies. Two individuals independently performed abstract and full-text review, data extraction, and quality assessment of the papers. The prevalence and incidence of SLE were pooled through random effects model. Pooled estimates were expressed with 95% confidence. Out of 2340 papers, 23 studies were included in the review. The mean age at diagnosis ranged from 25.5 to 45.8 years. Three studies were conducted in Argentina and Brazil, two studies in China and one study in Cuba, Colombia, Democratic Republic Congo, Ecuador, Egypt, India, Kenya, Malaysia, Mexico, Nigeria, Pakistan, Turkey, Ukraine, Venezuela, and Zimbabwe. The SLE prevalence and incidence varied from 3.2 to 159 per 100,000 and 0.3–8.7 per 100,000 persons, respectively. In a random effects meta-analysis (n = 10), the pooled prevalence of SLE was 103 (95% confidence interval [CI] – 17 to 224) per 100,000. Meta‐analysis of data from 6 incidence studies revealed an incidence of 5 cases per year (95% CI 2–8) per 100,000. According to WHO regions, the pooled prevalence of American and Western Pacific regions was 300 (95% CI – 200 to 900) and 36 (95% CI 35–37) per 100,000, respectively. The pooled incidence of the American region was 10 (95%, 0–14) per 100,000 inhabitants. Systemic lupus erythematosus is a common disease with considerable variation in prevalence and incidence among the general population in LMICs. Accurate estimates of prevalence and incidence of SLE are required to put in place appropriate programmes to reduce its burden in LMICs. PROSPERO registration number: CRD: 42020197495, https://www.crd.york.ac.uk/prospero/.

show abstract

Characterisation of Patients with Systemic Lupus Erythematosus in Malta: A Population Based Cohort Cross-Sectional Study

Cited by 16 publications

References 33 publications

Sarcopenia e excesso de peso em mulheres portadoras de lúpus eritematoso sistêmico

Sarcopenia e excesso de peso em mulheres portadoras de lúpus eritematoso sistêmico

Risk factors of perioperative complications and transfusion following total hip arthroplasty in systemic lupus erythematosus patients

Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis

Contact Info

Product

Resources

About